세계의 방광경 시장 규모 분석 : 제품별, 용도별, 최종 용도별, 유형별, 지역별 예측(2022-2032년)

The global cystoscope market was valued at approximately USD 1.12 billion in 2023 and is projected to grow at a CAGR of 9.99% from 2024 to 2032. The increasing prevalence of urological and gynecological disorders, a growing geriatric population, and technological advancements in cystoscope devices are key factors driving the market.

Cystoscopes are widely used for the diagnosis and treatment of urinary tract disorders, bladder cancer, urinary incontinence, and urinary tract infections (UTIs). According to a 2024 study published by Elsevier Inc., 50%-60% of women experience at least one UTI in their lifetime, significantly increasing the demand for cystoscopic procedures. Additionally, a WHO report (2024) estimates that by 2030, around 16.66% of the global population will be aged 60 or older, contributing to a higher prevalence of urological conditions such as benign prostatic hyperplasia (BPH), bladder stones, and bladder cancer.

The rising incidence of bladder cancer is also a major growth driver for the cystoscope market. The International Agency for Research on Cancer (2022) reported that over 600,000 people worldwide were diagnosed with bladder cancer, leading to more than 220,000 deaths. Since cystoscopy is the primary diagnostic tool for bladder cancer, the increasing disease burden is expected to propel market demand over the forecast period.

Technological innovations are transforming cystoscopy procedures, improving patient comfort and diagnostic accuracy. For instance, UroViu Corp introduced the Uro-GHD in April 2023, a single-use, sterile cystoscope designed for enhanced flexibility and improved patient comfort. Additionally, Ambu Inc. received FDA approval for the aScope 4 Cysto in 2021, expanding the availability of video cystoscopy solutions. The adoption of single-use cystoscopes is rising due to infection control concerns, reducing the risk of cross-contamination and healthcare-associated infections (HAIs).

From a regional perspective, North America held the largest market share in 2023, driven by advanced healthcare infrastructure, increasing incidence of bladder cancer, and strong presence of key market players such as Olympus Corporation, Boston Scientific Corporation, and Ambu Inc.. Meanwhile, the Asia Pacific region is projected to witness the fastest growth, fueled by rising healthcare investments, increasing awareness of urological disorders, and expanding access to diagnostic facilities in countries such as China, India, and Japan.

Major Market Players Included in This Report:

• Olympus Corporation
• Boston Scientific Corporation
• Ambu Inc.
• KARL STORZ
• Advin Health Care
• Intuitive Surgical (SCHOLLY FIBEROPTIC GMBH)
• Stryker
• UroViu Corporation
• NeoScope Inc.
• OTU Medical
• HOYA Corporation (Pentax Medical)

The Detailed Segments and Sub-Segments of the Market are Explained Below:

By Product:

• Flexible Cystoscopes
• Rigid Cystoscopes

By Application:

• Urology
• Gynecology

By End Use:

• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgery Centers
• Others

By Type:

• Video Cystoscopes
• Fiberoptic Cystoscopes

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Colombia
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Kuwait
• Rest of Middle East & Africa

Years Considered for the Study Are as Follows:

• Historical Year - 2022
• Base Year - 2023
• Forecast Period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years (2022-2032).
• Annualized revenue projections and regional analysis for each market segment.
• Comprehensive geographical landscape analysis with country-level insights.
• Competitive landscape review, including leading market players.
• Strategic recommendations for future market approaches.
• Detailed analysis of market structure and competitive dynamics.
• In-depth demand-side and supply-side market assessments.

Table of Contents

Chapter 1. Global Cystoscope Market Executive Summary

• 1.1. Global Cystoscope Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product
  • 1.3.2. By Application
  • 1.3.3. By End Use
  • 1.3.4. By Type
• 1.4. Key Market Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Cystoscope Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Cystoscope Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Prevalence of Urological and Gynecological Disorders
  • 3.1.2. Growing Geriatric Population and Rising Cases of Urinary Incontinence
  • 3.1.3. Technological Advancements in Cystoscope Devices
• 3.2. Market Challenges
  • 3.2.1. High Cost of Advanced Cystoscope Devices
  • 3.2.2. Stringent Regulatory Compliance & Safety Standards
• 3.3. Market Opportunities
  • 3.3.1. Rising Demand for Minimally Invasive Procedures
  • 3.3.2. Increasing Adoption of Single-Use Cystoscopes

Chapter 4. Global Cystoscope Market Industry Analysis

• 4.1. Porter's Five Forces Analysis
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's Five Forces Model
  • 4.1.7. Porter's Five Forces Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political Factors
  • 4.2.2. Economic Factors
  • 4.2.3. Social Factors
  • 4.2.4. Technological Factors
  • 4.2.5. Environmental Factors
  • 4.2.6. Legal Factors
• 4.3. Investment & Funding Landscape
• 4.4. Top Investment Opportunities
• 4.5. Competitive Landscape & Key Market Strategies
• 4.6. Regulatory & Policy Framework
• 4.7. Industry Expert Perspective
• 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Cystoscope Market Size & Forecasts by Product (2022-2032)

• 5.1. Segment Dashboard
• 5.2. Market Revenue Trend Analysis (2022 & 2032)
  • 5.2.1. Flexible Cystoscopes
  • 5.2.2. Rigid Cystoscopes

Chapter 6. Global Cystoscope Market Size & Forecasts by Application (2022-2032)

• 6.1. Segment Dashboard
• 6.2. Market Revenue Trend Analysis (2022 & 2032)
  • 6.2.1. Urology
  • 6.2.2. Gynecology

Chapter 7. Global Cystoscope Market Size & Forecasts by End Use (2022-2032)

• 7.1. Segment Dashboard
• 7.2. Market Revenue Trend Analysis (2022 & 2032)
  • 7.2.1. Hospitals
  • 7.2.2. Diagnostic Imaging Centers
  • 7.2.3. Ambulatory Surgery Centers
  • 7.2.4. Others

Chapter 8. Global Cystoscope Market Size & Forecasts by Type (2022-2032)

• 8.1. Segment Dashboard
• 8.2. Market Revenue Trend Analysis (2022 & 2032)
  • 8.2.1. Video Cystoscopes
  • 8.2.2. Fiberoptic Cystoscopes

Chapter 9. Global Cystoscope Market Size & Forecasts by Region (2022-2032)

• 9.1. North America
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Mexico
• 9.2. Europe
  • 9.2.1. UK
  • 9.2.2. Germany
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Denmark
  • 9.2.7. Sweden
  • 9.2.8. Norway
  • 9.2.9. Rest of Europe
• 9.3. Asia-Pacific
  • 9.3.1. Japan
  • 9.3.2. China
  • 9.3.3. India
  • 9.3.4. Australia
  • 9.3.5. South Korea
  • 9.3.6. Thailand
  • 9.3.7. Rest of Asia-Pacific
• 9.4. Latin America
  • 9.4.1. Brazil
  • 9.4.2. Argentina
  • 9.4.3. Rest of Latin America
• 9.5. Middle East & Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. South Africa
  • 9.5.4. Kuwait
  • 9.5.5. Rest of Middle East & Africa

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
  • 10.1.1. Olympus Corporation
  • 10.1.2. Boston Scientific Corporation
  • 10.1.3. Ambu Inc.
• 10.2. Market Strategies of Leading Players
• 10.3. Company Profiles
  • 10.3.1. KARL STORZ
  • 10.3.2. Advin Health Care
  • 10.3.3. Intuitive Surgical (SCHOLLY FIBEROPTIC GMBH)
  • 10.3.4. Stryker
  • 10.3.5. UroViu Corporation
  • 10.3.6. NeoScope Inc.
  • 10.3.7. OTU Medical
  • 10.3.8. HOYA Corporation (Pentax Medical)

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes